Skip to content

Labcorp Holdings LH Debt Repayments

Debt Repayments at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$0-100%
Quest Diagnostics logo
Quest DiagnosticsDGX
$500M+24.7%
NeoGenomics logo
NeoGenomicsNEO
$50.31M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$355.68M+138%
Exagen Inc. logo
Exagen Inc.XGN
$168K+57.0%
IQVIA logo
IQVIAIQV
$687M+1,461%

Other financials

Income statement

See full
Revenue$3.7B+5.8%
Gross profit$1.1B+6.3%
Operating income$451.6M+14.5%
Net income$298.7M+25.6%
EPS (diluted)$3.64+28.2%

Balance sheet

See full
Cash & equivalents$141.8M-78.1%
Total debt$6.8B+11.8%
Total equity$8.6B+1.6%
Total assets$18.5B+2.6%

Cash flow

See full
Operating cash flow$445.5M-28.2%
CapEx$131.6M+68.9%
Free cash flow$313.9M-42.2%

Valuation

See full
Market cap$25.77B+18.8%
Enterprise value$32.39B+19.5%
P/E25.7×-2.7×
P/S1.8×+0.2×

Profitability

See full
Gross margin28.9%+0.7pp
Operating margin10.4%+1.6pp
Net margin7%+1.3pp
FCF margin8.1%-1.3pp

Returns & leverage

See full
Return on equity11.7%+2.5pp
Debt / equity0.8×+0.1×
Current ratio1.8×+0.3×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfSeniorDebt.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's debt repayments?
Labcorp Holdings (LH) reported debt repayments of $0 in Q1 2026.
How has Labcorp Holdings's debt repayments changed year-over-year?
Labcorp Holdings's debt repayments decreased by 100.0% year-over-year, from $1B to $0.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.